Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
<h4>Aims</h4>Inflammatory osteolysis is sine-qua-non of active Charcot neuroarthropathy (CN) causing decreased foot bone mineral density (BMD) and fractures. We aimed to explore the effect of anti-inflammatory or anti-resorptive agents for effect on foot bone mineral content (BMC) and co...
Guardado en:
Autores principales: | Liza Das, Ashu Rastogi, Edward B Jude, Mahesh Prakash, Pinaki Dutta, Anil Bhansali |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/494cf51595df41e8a7ea788cf65345a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus
por: Liza Das, et al.
Publicado: (2021) -
Surgical treatment of Charcot foot with purulent infection
por: Valeriy Afanas'evich Mitish, et al.
Publicado: (2009) -
Criteria of immobilization duration of the affected foot in diabetic Charcot neuro-osteoarthropathy
por: Anastasia Gennad'evna Demina, et al.
Publicado: (2014) -
A prospective randomized controlled trial of bone metabolism in patients with charcot foot
por: Ekaterina L. Zaitseva, et al.
Publicado: (2020) -
Short-term outcomes of treatment of active stage of Charcot foot in outpatient setting
por: Anastasia G. Demina, et al.
Publicado: (2020)